Physician profile
Ceeccy Yang
NPI 1780767640
$2,162.45
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $466 · 2021: $648 · 2022: $515 · 2023: $74.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $626.12 | 2019-2022 | |
| Intuitive Surgical, INC. | $297.96 | 2019-2020 | |
| Daiichi Sankyo INC. | $237.37 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $97.55 | 2021-2022 | |
| Therapeuticsmd, INC. | $92.88 | 2019-2022 | |
| Ethicon US, LLC | $88.57 | 2020 | |
| Myovant Sciences INC. | $77.57 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.92 | 2021-2022 | |
| Exeltis, USA INC. | $64.38 | 2019-2022 | |
| Aspira Women'S Health INC | $60.16 | 2023 | Ova1 |
| Allergan, INC. | $54.14 | 2019-2020 | |
| Avion Pharmaceuticals | $54.04 | 2020-2022 | |
| Evofem Biosciences, INC. | $48.79 | 2020-2021 | |
| Channel Medsystems, INC. | $48.29 | 2022 | |
| Hologic Sales and Service, LLC | $41.99 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $31.16 | 2020-2021 | |
| Teleflex LLC | $27.09 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $23.67 | 2019-2020 | |
| Pfizer INC. | $16.03 | 2021 | |
| Astellas Pharma US INC | $15.63 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.28 | 2019 | |
| Scynexis, INC. | $14.24 | 2022 | |
| Amgen INC. | $13.94 | 2023 | Otezla, Repatha |
| Agile Therapeutics, INC. | $13.21 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.95 | 2022 | |
| Novo Nordisk INC | $11.80 | 2020 | |
| Zyla Life Sciences, INC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ceeccy Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.